DEGRADABLE SPIRAL COATED STENT WITH CONTROLLABLE GRADIENT, PREPARATION METHOD THEREFOR AND USE THEREOF
申请人:Zhuhai Ruizhan Biomaterials Co., Ltd.
公开号:EP3818995A1
公开(公告)日:2021-05-12
Disclosed are a spiral coated stent with controllable gradient degradation, a preparation method thereof and an application thereof. The spiral coated stent with controllable gradient degradation is composed of a degradable medical polyurethane and a degradable magnesium alloy material, wherein the degradable medical polyurethane contains a following chemical structure: PCL-PEG-PCL, wherein a molecular weight of the PEG is 200 to 1,000 and the molecular weight of the PCL is 200 to 10,000, and the degradable magnesium alloy material is of a spiral stent structure; and physical properties of the spiral coated stent with controllable gradient degradation need to satisfy the following technical parameters that: a breaking strength needs to be no less than 1 N, a pressure resistance needs to be no less than 2 N, and a degradation characteristic of the magnesium alloy after surface treatment shows gradient degradation with different time.
[EN] DEGRADATION TIME CONTROLLABLE AND BREAKING ELONGATION ADJUSTABLE MEDICAL DEGRADABLE POLYURETHANE<br/>[FR] POLYURÉTHANE MÉDICAL DÉGRADABLE AJUSTABLE EN TERMES D'ALLONGEMENT À LA RUPTURE ET À TEMPS DE DÉGRADATION RÉGLABLE<br/>[ZH] 降解时间可控、断裂伸长率可调的医用可降解聚氨酯
[EN] DEGRADABLE SPIRAL COATED STENT WITH CONTROLLABLE GRADIENT, PREPARATION METHOD THEREFOR AND USE THEREOF<br/>[FR] STENT ACTIF EN SPIRALE DÉGRADABLE À GRADIENT CONTRÔLABLE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION<br/>[ZH] 一种可控梯度降解螺旋状覆膜支架、其制备方法及其用途
PREPARATION OF (R)-3-AMINOPIPERIDINE DIHYDROCHLORIDE
申请人:Takeda Pharmaceutical Company Limited
公开号:EP1999108A1
公开(公告)日:2008-12-10
SPIRAL COATED STENT WITH CONTROLLABLE GRADIENT DEGRADATION, PREPARATION METHOD THEREOF AND APPLICATION THEREOF
申请人:Zhuhai Ruizhan Biomaterials Co., Ltd.
公开号:US20210128795A1
公开(公告)日:2021-05-06
Disclosed are a spiral coated stent with controllable gradient degradation, a preparation method thereof and an application thereof. The spiral coated stent with controllable gradient degradation is composed of a degradable medical polyurethane and a degradable magnesium alloy material, wherein the degradable medical polyurethane contains a following chemical structure: PCL-PEG-PCL, wherein a molecular weight of the PEG is 200 to 1,000 and the molecular weight of the PCL is 200 to 10,000, and the degradable magnesium alloy material is of a spiral stent structure; and physical properties of the spiral coated stent with controllable gradient degradation need to satisfy the following technical parameters that: a breaking strength needs to be no less than 1 N, a pressure resistance needs to be no less than 2 N, and a degradation characteristic of the magnesium alloy after surface treatment shows gradient degradation with different time.